Robert M Riggs

Title: Innovations of Robert M Riggs

Introduction

Robert M Riggs is an accomplished inventor based in Birmingham, AL (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of prodrugs that enhance the efficacy and safety of various therapeutic agents. His innovative work has led to the creation of a patent that addresses important medical needs.

Latest Patents

Robert M Riggs holds a patent for "Permeable, non-irritating prodrugs of nonsteroidal and steroidal agents." This patent describes prodrugs containing an active drug molecule linked to a polyethylene glycol group. The patent outlines a method of using these prodrugs, which include soluble ester prodrugs containing naproxen, triamcinolone acetonide, gancyclovir, taxol, cyclosporin, dideoxyinosine, trihydroxy steroids, and flurbiprofen molecules linked to polyethylene glycol (PEG) groups. Additionally, it details pharmaceutical compositions containing these prodrugs and methods for treating various disease states or symptoms.

Career Highlights

Robert M Riggs is associated with the University of Kentucky Research Foundation, where he has been able to leverage his expertise in pharmaceutical sciences. His work has not only contributed to the academic community but has also had practical implications in the medical field.

Collaborations

Throughout his career, Robert has collaborated with notable colleagues, including Peter G Glavinos and Grazyna Cynkowska. These collaborations have further enriched his research and development efforts, leading to advancements in drug formulation and delivery.

Conclusion

Robert M Riggs is a notable inventor whose work in the field of prodrugs has the potential to significantly impact pharmaceutical therapies. His innovative approach to drug development continues to pave the way for new treatment options.